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Background: Over the recent years the production of Ehrlich pathway derived chemicals was shown in a variety of
hosts such as Escherichia coli, Corynebacterium glutamicum, and yeast. Exemplarily the production of isobutyric acid
was demonstrated in Escherichia coli with remarkable titers and yields. However, these examples suffer from
byproduct formation due to the fermentative growth mode of the respective organism. We aim at establishing a
new aerobic, chassis for the synthesis of isobutyric acid and other interesting metabolites using Pseudomonas
sp. strain VLB120, an obligate aerobe organism, as host strain.
Results: The overexpression of kivd, coding for a 2-ketoacid decarboxylase from Lactococcus lactis in Ps. sp. strain
VLB120 enabled for the production of isobutyric acid and isobutanol via the valine synthesis route (Ehrlich pathway).
This indicates the existence of chromosomally encoded alcohol and aldehyde dehydrogenases catalyzing the
reduction and oxidation of isobutyraldehyde. In addition we showed that the strain possesses a complete pathway
for isobutyric acid metabolization, channeling the compound via isobutyryl-CoA into valine degradation. Three key
issues were addressed to allow and optimize isobutyric acid synthesis: i) minimizing isobutyric acid degradation by
host intrinsic enzymes, ii) construction of suitable expression systems and iii) streamlining of central carbon metabolism
finally leading to production of up to 26.8 ± 1.5 mM isobutyric acid with a carbon yield of 0.12 ± 0.01 g gglc
-1 .
Conclusion: The combination of an increased flux towards isobutyric acid using a tailor-made expression system and
the prevention of precursor and product degradation allowed efficient production of isobutyric acid in Ps. sp. strain
VLB120. This will be the basis for the development of a continuous reaction process for this bulk chemicals.
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The finite nature of fossil resources necessitates the de-
velopment of new technologies for the production of che-
micals based on natural renewable feedstocks. So far,
approximately 90% of all chemicals are produced from
fossil-based supplies, but the world market for bio-based
chemicals is expected to increase from $US 3.6 billion in
2011 to $US 12.2 billion in 2021 [1-3]. The rapid progress
in the fields of metabolic engineering and systems biology
accelerates this development and allows the synthesis of
non-natural and non-inherent products [4]. Atsumi et al.
[5] showed the production of higher alcohols via the* Correspondence: katja.buehler@bci.tu-dortmund.de
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reproduction in any medium, provided the oramino acid catabolism by integrating the Ehrlich pathway
into Escherichia coli. 2-keto acid intermediates were dec-
arboxylated to the corresponding aldehydes using the 2-
keto acid decarboxylase Kivd from Lactococcus lactis and
were further converted by (host intrinsic) alcohol dehydro-
genases to higher alcohols. Zhang et al. [6] demonstrated
the successful oxidation of isobutyraldehyde to isobutyric
acid in E. coli, by overexpressing an aldehyde dehydro-
genase. Isobutyric acid is mainly used as a precursor for
methacrylic acid production and has a market size of
about 2.7 ∙ 106 t a-1. In addition, isobutyric acid can be uti-
lized for the production of sucrose acetoisobutyrate, texa-
nol or di-isobutyrate [7]. Isobutyric acid can be chemically
produced by reacting propene, carbon monoxide, and
water in the presence of strong acids [8]. This chemical
route suffers from its dependency on fossil products of oild. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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compounds harmful to the environment such as sulfuric
acid, hydrogen fluoride, and boron fluoride [6].
A major bottleneck of current bioprocesses is the sus-
ceptibility of microorganisms to toxic compounds [9,10].
This results in low product titers and limited process sta-
bilities having a negative impact on overall productivity.
The cost competitiveness of biocatalytic processes is de-
termined by these parameters [11] and it is indispensable
to overcome these limitations. Pseudomonas species are
known to exhibit mechanism enabling the adaptation to
toxic environmental conditions [12]. Importantly, these
organisms are able to form stable surface associated mi-
crobial communities (biofilms), which have been described
as potent alternative to planktonic cells regarding their ap-
plication as biocatalyst, especially when solvents or other-
wise toxic compounds are involved in the processes [13].
Biofilms provide increased process stability and therefore
potentially allow, in contrast to commonly used planktonic
cells, a continuous process mode [14,15].
Pseudomonads have a huge potential for bioremedi-
ation, and possess a rich pathway repertory for the degrad-
ation of a variety of non-natural and non-inherent toxic
compounds such as aromatic organics [16-19]. Carbon is
utilized in Pseudomonas wild types almost without the
production of byproducts such as acetate [20], lactate, gly-
cerol or ethanol, which improves carbon yields and simpli-
fies downstream processing in comparison to organisms
like Escherichia coli, Bacillus subtilis, and Saccharomyces
cerevisiae [21]. Under anaerobic and micro aerobic condi-
tions, E. coli needs to produce mixed-acids directly from
the key-precursor pyruvate to maintain an optimal redox
and carbon environment for isobutyric acid synthesis, fi-
nally limiting the final carbon yield and affecting the
downstream processing. In aerobic environment E. coli is
known for its overflow metabolism under glucose excess
conditions resulting in acetate formation [22].
So far, mainly aromatic compounds are produced using
recombinant Pseudomonas strains. The fermentative de-novo
synthesis of e.g. phenol, p-coumarate, p-hydroxystyrene,
t-cinnamate, and several polyhydroxyalkanoates [9,23-27]
from glucose have been reported as well as biotransfor-
mations using toluene or styrene for the production of
3-methylcatechol and (S)-styrene oxide [28,29]. Moreover,
Nielsen et al. [30] reported the fermentative production ofTable 1 Influence of yeast extract on product titers of isobuty
Isobutyric acid [μM]
M9* 5.4 ± 1.3
M9* + 5 g L-1 yeast extract 56.4 ± 1.5
Cultivations (72 h) were done in M9* medium with 20 g L-1 glucose in sealed shake
strain VLB120 pCOM10-kivd. kivd overexpression was induced with 0.05% (v/v) DCP
without overexpression of kivd none of the listed products were detectable. Errors i1-butanol using an engineered Pseudomonas putida S12.
Here the term ‘fermentation’ describes synthesis of the tar-
get product by whole cells directly from the added carbon
and energy source, whereas ‘biotransformation’ refers to
processes, where in addition to the growth substrate a bio-
transfomation substrate is added [31].
This study aims to establish the solvent tolerant,
genome-sequenced Pseudomonas sp. strain VLB120 [29,32]
as a platform biocatalyst for the fermentative production
of isobutyric acid. Therefore the Ehrlich pathway is incor-
porated into a Pseudomonad with the aim to produce iso-
butyric acid via the valine synthesis pathway. In this work,
strain specific limitations of Pseudomonas like low ex-
pression levels of recombinant genes and product and pre-
cursor degradation were solved by means of metabolic
engineering.
Results
Overexpression of a 2-keto acid decarboxylase encoding
gene in Pseudomonas sp. strain VLB120 allows the synthesis
of isobutyric acid and isobutanol
To evaluate the application of Ps. sp. strain VLB120 for
the synthesis of isobutyric acid, the 2-keto acid decarb-
oxylase Kivd from Lactococcus lactis was produced using
a pCOM10 expression system. The resulting Ps. sp. strain
VLB120 pCOM10-kivd produced isobutyric acid, iso-
butanol, and 3-methyl-1-butanol directly from glucose
(Table 1). The presence of isobutanol and isobutyric acid
indicate the existence of host intrinsic alcohol and alde-
hyde dehydrogenases in Ps. sp. strain VLB120 capable to
oxidize or reduce isobutyraldehyde. In abiotic experiments
no isobutyric acid formation could be detected. Product ti-
ters were significantly increased by the addition of yeast
extract, which can serve as carbon precursor for the de-
sired products. The production of 3-methyl-1-butanol can
be explained by a withdrawal of 2-keto-isocaproate, the
precursor of leucine biosynthesis, which is first decarboxy-
lated and then reduced by host intrinsic enzymes to the
corresponding alcohol [33].
Product and precursor degradation in Pseudomonas sp.
strain VLB120
Pseudomonas species are known for their ability to utilize a
variety of organic molecules as growth substrates [16]. This
ability may contradict process efficiency by product orric acid, isobutanol and 3-methyl-1-butanol
Isobutanol [μM] 3-methyl-1-butanol [μM]
43.1 ± 0.4 50.0 ± 1.4
72.1 ± 2.9 236.5 ± 0.4
flasks at 30°C with and without 5 g L-1 yeast extract using Pseudomonas sp.
K at early exponential phase. In cultures of Pseudomonas sp. strain pCOM10
ndicate standard deviations (n = 2).
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product and/or precursors are degraded, growth experi-
ments, using the respective compounds as sole carbon
source were conducted (Table 2). Ps. sp. strain VLB120
is able to grow on all tested compounds with different
carbon yields and growth rates. After pre-growth in the
presence of the respective substrates to allow cell me-
tabolism to adapt, isobutyric acid, isobutyraldehyde, and
2-ketoisovalerate (2-KIV) were converted allowing ex-
ponential growth rates between of 0.15 and 0.24 h-1,
with the exception of isobutanol where only slow growth
was observed. Biomass yields from glucose for isobuty-
ric acid, and isobutyraldehyde are in the same range,
while conversion of 2-KIV led to lower final biomass
concentrations.
To optimize isobutyric acid production precursor and
product degradation needed to be prevented or at least
minimized. Based on the growth experiments and gen-
omic data a map was constructed showing the overall
pathways for isobutyric acid synthesis and its degrad-
ation in Ps. sp. strain VLB120 using glucose as carbon
source (Figure 1).
Deletion of branched chain 2-keto acid dehydrogenase
(bkd) strongly increases product titers in 2-KIV
biotransformations
The degradation of valine was extensively investigated in P.
putida and it was demonstrated that a branched chain
α-keto acid dehydrogenase complex consisting of three pro-
teins is responsible for the oxidation of 2-KIV to isobutyryl-
CoA, which is further degraded to propionyl-CoA [34,35]
(Figure 2). In the genome of Ps. sp. strain VLB120, a ho-
molog of this gene cluster (PVLB_17450, PVLB_17455,
PVLB_17460 and PVLB_17465) was identified. To prevent
the degradation of 2-KIV the gene coding for the E1
subunit of the branched chain 2-keto acid dehydrogenase
(PVLB_17450) was deleted. The resulting Δbkd strain could
not grow on 2-KIV as sole carbon source anymore (data
not shown). Degradation of 2-KIV was investigated in Ps.Table 2 Growth rate (μ) and biomass yield (Y) of
Pseudomonas sp. strain VLB120 on different carbon
sources
Carbon source μ (h-1) Y (gcdw/gcarbon source)
Glucose 0.41 ± 0.01 0.64 ± 0.01
2-KIV 0.24 ± 0.03 0.39 ± 0.05
Isobutyraldehyde 0.24 ± 0.01 0.52 ± 0.01
Isobutyric acid 0.15 ± 0.02 0.59 ± 0.04
Isobutanol 0.025 ± 0.001 n.d.
Cells were cultivated in sealed shake flasks at 30°C on 10 mM of different carbon
sources in M9* medium pH 7.0. Errors indicate standard deviations (n = 2 - 5).
n.d.: not determined due to very slow growth (long time experiments result in
errors caused by oxygen limitation and/or isobutanol evaporation).sp. strain VLB120 Δbkd and the wild type strain, both har-
boring pCOM10-kivd (Figure 2). The mutant showed a
lower degradation rate of 2-KIV, whereas the production
titer of isobutanol and isobutyric acid increased signifi-
cantly. Isobutyric acid accumulated over the first 30 h and
was metabolized completely over the next 40 h, while iso-
butanol was again degraded at a slow rate (Figure 2, see
also Table 2).Random mutagenesis to prevent isobutyric acid
degradation
Isobutyric acid is a carbon and energy source for
Pseudomonas species and knowledge about the enzymes
responsible for its degradation is limited. Godhue et al. [36]
showed the whole-cell biotransformation of isobutyrate to
L-(+)-3-hydroxyisobutyrate in P. putida ATCC21244. This
indicates the existence of an enzyme activity catalyzing the
reaction from isobutyric acid to isobutyryl-CoA, which is a
metabolite in the natural valine degradation pathway. Ran-
dom mutagenesis of Ps. sp. strain VLB120Δbkd using N-
methyl-N’-nitro-N-nitrosoguanidine (NTG) was performed
to mutate the respective genes. NTG is one of the most
widespread chemical mutagens, and well known for its
ability to create auxotrophic mutants [37]. In Pseudomonas
species, it was used amongst others to optimize cinnamic
acid and phenol production [9,38]. The optimal comprom-
ise between cell survival rate and auxothrophy frequency
was found at a NTG concentration of 80 μg mL-1, which is
comparable to other reports [9,39]. We modified a method,
which was used by Martin et al. [40] to create mutants of
the valine degradation pathway. Mutants showing no alter-
ation in growth on glucose and succinate but a drastically
decreased growth rate and/or lag phase on isobutyric acid,
were selected for further investigation (Additional file 1:
Figure S1). 2-KIV biotransformations were performed with
NTG-mutants harboring pCOM10-kivd (Figure 3). All mu-
tants showed a change in their 2-KIV conversion rate.
Some mutants (A10, A21, B57, B83, C82, D67) accumu-
lated 3-hydroxyisobutyric acid and isobutyric acid, others
only isobutyric acid (C18, D76, E82). Surprisingly, all mu-
tants except D67 lost their ability to accumulate isobutanol
even temporarily under these conditions. This product was
only observed in resting cell assays, when 10 mM isobutyr-
aldehyde were applied as substrate (Additional file 1: Figure
S2). Mutant C18 was chosen as the candidate for further
strain development, as it produced isobutyric acid with the
highest yield compared to Ps. sp. strain VLB120Δbkd and
no product degradation could be detected.
In general, 2-KIV biotransformations showed a max-
imum yield of approximately 50% isobutyric acid from
2-KIV. This compound serves as a precursor for leucine,
valine and panthothenic acid synthesis which negatively
influences the final yield (Figure 1).
Figure 1 Pathways for isobutyric acid synthesis and its degradation in Ps. sp. strain VLB120. OM: outer membrane, IM: inner membrane,
ADH: alcohol dehydrogenase, ALDH: aldehyde dehydrogenase, alsS: acetolactate synthase, bkd: branched-chain alpha-keto acid dehydrogenase
gene cluster, gcd: glucose dehydrogenase, ilvC: ketol-acid reductoisomerase, ilvD: dihydroxy acid dehydratase, ilvE: branched-chain-amino-acid
transaminase, kivd: 2-keto acid decarboxylase, leuA: 2-isopropylmalate synthase, leuB: 3-isopropylmalate dehydrogenase, leuC: isopropylmalate
isomerase, mmsA: methylmalonate-semialdehyde dehydrogenase, mmsB: 3–hydroxyisobutyrate dehydrogenase, pyc: pyruvate carboxylase, panB:
ketopantoate hydroxymethyl transferase, panE: ketopantoic acid reductase, panC pantothenate synthetase [19,40,53].
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Ehrlich pathway genes showed increased enzyme activity
for each single protein
To increase the flux to 2-KIV, the respective genes of the
valine synthesis pathway were overexpressed in Ps. sp.
strain VLB120 T7. This strain was developed to guarantee
stable and high expression levels in the desired host under
fermentative conditions. T7 promoter dependent expres-
sion turned out to be beneficial, as compared to Palk-
dependent expression (Additional file 1: Figure S2). Ps. sp.
strain VLB120 T7 was transformed with plasmids pPAPC-
Km and pPDPK. For details on plasmid construction
please see materials and methods. Activities for AlsS, IlvC,
IlvD and Kivd were determined in crude cell extracts, and
compared to activities in extracts of the wild type and Ps.
sp. VLB120 pCOM10-kivd (Table 3).
All proteins showed higher specific activities in the de-
sired production host as compared to the wild type strain.Under the fermentation conditions used, Kivd activity in
Ps. sp. strain pCOM10-kivd was not even detectable, being
in line with the eGFP expression study (Additional file 1:
Figure S2), and demonstrated the advantage of T7 expres-
sion in Ps. sp. strain VLB120.
Overexpression of the 2-KIV and Ehrlich pathway in the NTG
mutant C18 T7 results in stable isobutyric acid production
2-KIV and Ehrlich pathway overexpression in Ps. sp. strain
VLB120 T7 (Figure 4A) and in the genetic engineered vari-
ant C18 T7 (Figure 4B) resulted in drastically increased
final isobutyric acid titers in aerobic fermentations. Shake
flask experiments were carried out with carbon concen-
trations of 20 g L-1 glucose to avoid a pH drop. Cells
were induced with 1 mM ITPG at an OD450 of about 10
(1.86 gcdw L
-1) to obtain sufficient cell densities. After in-
duction, the biomass concentration stayed almost constant
during the rest of the experiment. By overexpressing the 2-


























































































Figure 3 Maximum achievable product titers of isobutyric acid, 3-hydroxyisobutyric acid, and isobutanol during 2-ketoisovalerate
biotransformations. Growing Ps. sp. strain VLB120 NTG mutants transformed with pCOM10-kivd were utilized. Exemplarily concentration profiles
of 2-KIV, isobutanol and isobutyric acid in the NTG mutant Ps. sp. strain VLB120 C18 are highlighted in the upper left box. Cultivations were
performed in M9* pH 7.0, 5 g L-1 glucose in sealed shake flasks at 30°C. Cells were induced at early exponential phase with 0.05% (v/v) DCPK.
At the same time point 25 mM 2-KIV was added. Hatched bars denote concurrent product degradation. ▼: 2-ketoisovalerate, □: isobutyric acid,
○: isobutanol. (n = 1, due to expensive substrate).





























































Figure 2 Growing cell 2-ketoisovalerate biotransformations. Comparison of Ps. sp. strain VLB120 pCOM10-kivd (A) and Ps. sp. strain
VLB120Δbkd pCOM10-kivd (B). Cultivations were performed in M9* pH 7.0, 5 g L-1 glucose in sealed shake flasks at 30°C. Cells were induced at
early exponential phase with 0.05% (v/v) DCPK and 25 mM 2-KIV was added.▼: 2-ketoisovalerate, □: isobutyric acid, ○: isobutanol. Two independent
fermentations were performed, showing comparable results.
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Table 3 Specific activities of AlsS, IlvC, IlvD, Kivd in cell extracts of Pseudomonas sp. strain VLB120, Pseudomonas sp.
strain T7 pPAPC-Km, pPDPK and Ps. sp. strain VLB120 pCom10-kivd
Specific activity (μmol min-1 mgtotal protein
-1 )
AlsS IlvC IlvD Kivd
VLB120 wild type 0.033 ± 0.009 0.0257 ± 0.0017* 0.0075 ± 0.0004 ND
VLB120 T7 pPAPC-Km, pPDPK 3.494 ± 0.299 0.1476 ± 0.0425* 0.1955 ± 0.0023 2.96 ± 0.24
VLB120 pCOM10-kivd n.d. n.d. n.d. ND
ND: not detectable.
*: coupled assay together with AlsS.
Cells were cultured in M9* pH 7.4, 20 g L-1 glucose and. 5 g L-1 yeast extract shake flasks at 30° Cells were induced for 4 h either with 0.05% DCPK (pCOM10) or
with 1 mM IPTG (pPDPK, pPAPC-Km) in the early exponential phase. Errors indicate standard deviations (n = 2 - 3).
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was produced in both strains. The wild type degraded the
acid over the whole course of the experiment, traceable
with the formation of 3-hydroxyisobutyric acid, a degrad-
ation product of isobutyric acid. The degradation was pro-
nounced by glucose depletion resulting in the complete
product metabolization within the next 30 h. In mutant
C18 T7 no isobutyric acid degradation and, connected to
that no 3-hydroxyisobutyric acid formation, was detectable.
In both cases, glucose is partially converted to gluconate
prior to the utilization for product or biomass gener-
ation. While the wild type completely exploited the car-
bon sources, C18 T7 did not completely convert the
generated gluconate.
Deletion of pathways competing for 2-ketoisovalerate
and pyruvate increased carbon yield
In addition to the direct bypass of 2-KIV in the valine deg-
radation pathway (catalyzed by bkd), 2-KIV is the precursor
for the amino acids valine and leucine and the vitamin pan-
tothenic acid in Pseudomonas. The branched-chain amino
acid aminotransferase IlvE catalyzes, amongst others, the


























Figure 4 Isobutyric acid production during a representative fermenta
pPAPC-Km, pPDPK (B) were cultivated in M9* pH 7.4 medium initially cont
with 1 mM IPTG at timepoint 0 h at an OD450 of 10. ▼: glucose, ◊: glucona
Δ: 3-hydroxyisobutyric acid. Three independent fermentations were performsynthase LeuA catalyzes the first step in leucine synthesis
and PanB is a 2-ketoisovalerate hydroxymethyltransferase.
To optimize the carbon yield, these competing pathways
for 2-KIV were deleted. In addition, the genes coding for
the pyruvate carboxylase (pycAB) were removed to prevent
pyruvate withdrawal into the TCA-cycle due to anaplerosis.
Single knockout mutants of ΔilvE, ΔleuA, ΔpanB, and
ΔpycAB, and combined mutants of genes involved in 2-
KIV metabolism were created and strains were trans-
formed with production plasmids pPAPC-km and pPDPK.
Figure 5 shows the results of fermentations conducted with
a starting concentration of 20 g L-1 glucose in shake flasks.
By deleting panB, the titer could be increased about
2.5-fold, ilvE deletion lead to a 1.5-fold increase. Mutants
without a functional 2-isopropylmalate synthase showed
decreased titers in single- as well as in double knock-outs.
The deletion of the pycAB genes did not significantly influ-
ence the final titer of isobutyric acid.
Discussion
In the present study, different variants of recombinant
Ps. sp. strain VLB120 have been constructed by means




































tion. Ps. sp. strain VLB120 T7. pPAPC-Km, pPDPK (A) and C18 T7
aining 20 g L-1 glucose and 5 g L-1 yeast extract. Cells were induced
te, ♦: biomass concentration, □: isobutyric acid, ○: isobutanol,












































































Figure 5 Fermentation of different C18 T7 mutant strains
harboring the production plasmids pPAPC-km and pPDPK.
Cultivations were done in shake flasks in M9* pH 7.4 starting with
20 g L-1 glucose and 5 g L-1 yeast extract. Induction was conducted
with 1 mM IPTG at OD450 of 10. Error bars indicate standard
deviations (n = 2).
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glucose in aerobic fermentations with the focus on iso-
butyric acid synthesis.
Isobutyraldehyde metabolism in Ps. sp. strain VLB120
Overexpressing simply one gene encoding for a branched
chain 2-ketoacid decarboxylase (KivD) in Ps. sp. strain
VLB120, enabled this organism to produce isobutyric acid,
isobutanol, and 3-methyl-1-butanol, directly from glucose.
Isobutyraldehyde was not detected in the fermentation
broth, indicating direct intracellular conversion of this
compound. Based on genome analysis, 32 aldehyde dehy-
drogenases (Additional file 1: Table S2), and about 19 alco-
hol dehydrogenases (Additional file 1: Table S3) have been
identified in Ps. sp. strain VLB120 capable to either reduce
or oxidize isobutyraldehyde. Among these enzymes are
ALDHs homologs known to be highly active towards iso-
butyraldehyde (e.g. PVLB12825, a 42% homolog to padA
[7] of E .coli K12). In addition, the strain harbors ADHs
known to be able to catalyze the reduction of isobutyral-
dehyde (e.g. PVLB10545, a 86% homolog to adhP [41] of
E. coli K12). However, gene deletions of these candidate
genes did not significantly improve product titers (data not
shown). Rodriguez et al. [41], aiming to overproduce iso-
butyraldehyde in E. coli BW25113, identified eight ADHs
in the genome of E. coli BW25113 and observed that the
final product titer could only be increased by combining
multiple ADH deletions. While in E. coli BW25113 the
degradation of isobutyric acid is not described [7], thepresent work shows that Ps. sp. strain VLB120 harbors a
complete pathway for isobutyric acid utilization (Figure 1),
which enabled Ps. sp. strain VLB120 to grow on isobuta-
nol, isobutyraldehyde and isobutyric acid (Table 2). The
existence of an isobutyric acid degradation pathway was
already described for P. putida, Candida rugosa, Yarrowia
lipolytica and Desulfococcus multivorans and used in mu-
tant strains of the first three species for the synthesis of
3-hydroxyisobutyric acid using isobutyric acid as precur-
sor [36,42-45].
NTG-random mutagenesis to prevent isobutyric acid
degradation
To prevent undesired isobutyric acid degradation, several
mutants were created by random mutagenesis. The apparent
correlation between isobutyric acid and 3-hydroxyisobutyric
acid accumulation (in mutants B57, B83 and D67) indicates
the mmsAB operon (PVLB_03765, PVLB_03770) [46] cod-
ing for methylmalonate-semialdehyde-dehydrogenase and
3–hydroxyisobutyrate dehydrogenase to be involved in the
reaction of isobutyric acid to isobutyryl-CoA. Exemplarily,
the respective DNA loci were sequenced in mutants B83
and C18. The DNA sequencing revealed, that mmsB is al-
tered in variant B83. A transition (G/C → A/T) of nucleo-
tide 413 occurred, confirming that this special transition is
favored using NTG mutagenesis [47]. On the protein level,
this mutation leads to an exchange of the strictly conserved
residue Gly137 with asparagine [48] and thereby explains
the non-active 3-hydroxyisobutyirc acid dehydrogenase in
mutant B83. Mutant C18 shows no alteration in the
mmsAB operon. In this case, most probably a broad sub-
strate range acetyl-CoA-synthetase or a global regulator in-
volved in isobutyric acid degradation was affected by NTG
mutagenesis [45,49].
Fermentative production of isobutyric acid in engineered
Ps. sp. strain VLB120
The efficient fermentative production of isobutyric acid
requires the overexpression of the genes of the valine syn-
thesis pathway (alsS, ilvC, ilvD), a keto acid-decarboxylase
(kivd) and a highly expressed gene for an aldehyde de-
hydrogenase (ALDH). While ilvC, ilvD and the ALDH
gene are expressed homologously, alsS and kivd are de-
rived from other species and show an altered codon usage,
which often results in lower expression levels [50]. In
order to maximize expression levels and overcome pro-
moter related problems like catabolite repression by vari-
ous carbon sources [51], the so far used Palk promoter
was replaced by a T7 RNA polymerase based system.
Using eGFP fluorescence as a fast and easily detectable
read-out for expression (Additional file 1: Figure S2), the
performance of this system was evaluated confirming re-
cently published results for P. putida KT2440 T7 [52]. In
addition, enzyme activity assays of single pathway genes
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T7 (Table 3).
Overexpression of the 2-KIV synthesis pathway genes
and kivd in the T7 variants of Ps. sp. strain VLB120 resulted
in drastically increased isobutyric acid titers (Figure 4/
Table 1). In addition, the variant C18 T7 showed an in-
creased stability of the formed product, which confirms
the results of the 2-KIV biotransformations (Figure 2)
under fermentative conditions. During glucose utilization,
gluconate accumulated in Ps. sp. strain VLB120. This phe-
nomenon is well understood and described in Pseudomonas
species, which are known to metabolize glucose ex-
clusively via the Entner-Doudoroff pathway, using 6-
phosphogluconate as key intermediate [53]. Ps. sp. strain
VLB120 possesses a glucose dehydrogenase (PVLB_05240),
but is lacking a gluconate dehydrogenase, which prevents
2-ketogluconate formation. The incomplete conversion of
gluconate in mutant strain C18 T7 is comparable to the
behavior of Pseudomonas putida KT2440 during poly-
hydroxyalkonate synthesis observed by Poblete-Castro
et al. [54]. In their work, they enhanced the production of
PHAs by the deletion of glucose dehydrogenase without
affecting the specific growth rate. One may speculate, that
this deletion leads to an increased flux towards pyruvate
and thus more precursors for isobutyric acid synthesis
are available.
Optimization of isobutyric acid production by the
deletion of competing pathways
To prevent unproductive 2-KIV depletion via isobutyryl-
CoA or various amino acid synthesis pathways (Figure 1),
the influence of the genes bkd, ilvE, leuA, pycAB and panB
was investigated. The strongest effect on isobutyric acid ti-
ters was measured for the mutants ΔpanB and Δbkd. By
deleting subunit A of the branched chain α-keto acid
dehydrogenase complex (bkd), growth on 2-KIV could
be completely inhibited in Ps. sp. strain VLB120. Growth
could be restored by overexpressing the decarboxylase gene
kivd, channeling 2-KIV over isobutyraldehyde (Figure 1).
The mutant strain shows drastically increased product con-
centrations of isobutyric acid and isobutanol during 2-KIV
biotransformations, while during growth on glucose (fer-
mentation) this effect seems to be insignificant, as the pro-
duction rate of Ps. sp VLB120Δbkd C18-T7 harboring
Δbkd is comparable to Ps. sp VLB120. Under fermentative
conditions comprising high glucose und only low 2-KIV
concentrations the activation of 2-KIV to isobutyryl-CoA
seems to be only a minor carbon sink. Similar observations
have been reported by Lu et al. [55] for Ralstonia eutropha.
Deletion of ilvE helped to prevent undesired carbon loss,
this confirms similar results reported for C. glutamicum
and R. eutropha [55-57].
Deletion of panB had the strongest impact on carbon
yield for isobutyric acid synthesis. panB is the first geneof pantothenic acid synthesis pathway, and in addition a
precursor for CoA [58]. The deletion of panB seems to in-
crease 2-KIV availability, as also described for C. glutamicum
[59,60], and thereby results in an increased carbon yield of
0.12 ± 0.01 g g-1, which is about 25% of the theoretical
maximum. panB deletion leads to mutants unable to grow
on minimal medium (most probably connected to the dis-
ability to synthesize CoA).
For E. coli BW25113 10 g L-1 on a 5 mL scale using
40 g L-1 glucose has been reported [7] while for Ps. sp.
strain VLB120 2 g L-1 have been observed using only
20 g L-1 carbon source. Experiments have been conducted
in shake flasks with glucose excess where gluconate tem-
porarily accumulated resulting in a pH drop to pH 6.8
which was even more pronounced during isobutyric acid
formation. To prevent this pH drop, hampering catalyst
robustness, glucose needs to be limited and the pH con-
trolled. It is to be expected, that in such a controlled envir-
onment (bioreactor) higher final product titers and better
carbon yields will be reached.
Isobutyric acid production and beyond
In consequence, the application of the demonstrated de-
sign principles, the use of the genome sequence of Ps. sp.
strain VLB120 and the established metabolic engineering
tools, will give access to a far broader product spectrum.
Based on the engineered, highly active 2-KIV synthesis
pathway the production of isobutanol, 3-methyl-1-butanol,
3-hydroxyisobutyric acid, isobutyraldehyde, valine and D-
pantothenate would be feasible by slight pathway modifi-
cations. Beside the synthesis of isobutyric acid, we were
already able to detect the Ehrlich pathway products iso-
butanol and 3-methyl-1-butanol, which are interesting
bulk chemicals [33,61]. More over 3-hydroxyisobutytric
acid was accumulated in the not optimized mutant B83
with remarkable titers, being highly valuable synthons for
the fine chemical industry [62].
Conclusion
The combination of an increased flux towards isobutyric
acid using a tailor-made expression system and the pre-
vention of precursor and product degradation allowed
efficient production of isobutyric acid in Ps. sp. strain
VLB120. This work experimentally verifies the genome
derived metabolic network structure. A true platform or-
ganism was designed, which has the ability to produce
an even wider product spectrum directly from glucose
by only slight changes on the level of cell metabolism.
In general, studies investigating Pseudomonas for the
fermentative production of chemicals are few [19]. But
clear benefits like low/no byproduct formation during
glucose fermentation, high tolerance towards toxic sub-
stances [12], improved NAD(P)H regeneration rates under
stress conditions [21], and a diverse gene repertoire for
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tial of Pseudomonads for industrial applications. The
strain engineering of this novel organism sets the stage for
the development of aerobic biofilm based processes for
the continuous production of isobutyric acid and other
secondary metabolites. Apart from increasing product ti-
ters, the long-term catalyst robustness is a most important
but often neglected issue in host engineering, which will
be a key focus in future studies regarding this newly intro-
duced organism.
Methods
Chemicals, bacterial strains, and plasmids
All chemicals used in this study were purchased from
Sigma-Aldrich (Steinheim, Germany) or Carl Roth GmbH
(Karlsruhe, Germany), unless stated otherwise. The chemi-
cals were of the highest purity available and used without
further purification. The bacterial strains and plasmids
used in this study are listed in Table 4.
Cultivation of bacterial strains
Ps. sp. strain VLB120 was used as production host, while E.
coli DH5α and E. coli DH5α (λ-pir) served as host strains
for all plasmid based DNA manipulations. Ps. sp. strain
VLB120 and E. coli strains were cultivated at 200 rpm, 30°C
or 37°C (Infors AG, Bottmingen, Switzerland), respectively.
For all cloning purposes, transformations and first precul-
tures, cells were cultivated in lysogeny broth (LB, [70]). All
other cultivations were performed in M9* minimal medium
[71] which was supplemented with 1 mL L-1 US* trace
element solution [72] and 2 mL L-1 1 M MgSO4 solution.
For fermentations and cultivations used to prepare cell ex-
tracts, 5 g L-1 yeast extract and 0.001% (w/v) thiamine solu-
tion was added. Depending on the experiment, either
glucose (5 g L-1 or 20 g L-1), isobutyric acid (10 mM), iso-
butyraldehyde (10 mM), isobutanol (10 mM), succinate
(10 mM) or 2-ketoisovalerate (10 mM) served as carbon
sources. All media were supplemented with appropriate an-
tibiotics (kanamycin 50 μg mL-1 for E. coli and Ps. sp. strain
VLB120, gentamycin 25 μg mL-1 for E. coli and Ps. sp.
strain VLB120, chloramphenicol 34 μg mL-1 for E. coli).
For cultivations in minimal media, Ps. sp. strain VLB120
was cultivated in two subsequent precultures prior to the
main culture. First, the strain was cultivated for 8 h in
tubes filled with 5 mL LB overnight. 50 μL of this culture
was used as inoculum for a fresh 5 mL M9* culture. After
overnight growth 50 mL M9* medium in a 250 mL flask
were inoculated to an initial OD450 0.2. Ps. sp. strain
VLB120 cultures were either grown under aerobic condi-
tions in open baffled shake flasks or under micro aerobic
conditions in sealed baffled shake flasks to prevent the
evaporation of volatile compounds.
For experiments investigating the utilization of differ-
ent carbon sources by Ps. sp. strain VLB120 preculturederived cells were washed with M9* salt solution before
inoculating fresh M9* medium complemented with the
respective carbon source.
Random mutagenesis by N-methyl-N’-nitro-N-
nitrosoguanidine (NTG)
Random mutagenesis by NTG was performed according to
Adelberg et al. and Martin et al. [37,40]. 5 mL M9*-medium
(pH 7.4, 10 mM succinate as carbon source) was inocu-
lated with 50 μL of an 8 h LB culture of Ps. sp. strain
VLB120Δbkd and cultured overnight. This culture was
used to inoculate the main culture (250 mL M9*, 10 mM
succinate). Early exponential phase cells were harvested by
centrifugation (10 min, 4.500 g, 4°C), washed and concen-
trated in CpI-Buffer (127 mM Na2HPO4∙2H2O, 36.2 mM
Citric acid, pH 6.0) to an OD450 of 6 before 80 μg mL
-1
NTG was added. Cells were incubated for 30 min, washed,
resuspended in LB and stored for screening in 10% (w/v)
glycerol at −80°C.
Screening for NTG-mutants unable to degrade isobutyric
acid
To screen for mutants with changed properties regarding
isobutyric acid degradation, 5 mL M9* medium containing
10 mM succinate were inoculated with NTG treated cells
(see above). After overnight cultivation, cells were har-
vested by centrifugation, washed in identical medium with-
out carbon source, and used to inoculate fresh 5 mL M9*
medium with 10 mM isobutyric acid as sole carbon source
to an OD450 of 0.2. After reaching an OD450 of 0.4, solid
ampicillin was added up to its solubility limit (13 mg mL-1)
and cultivation was continued for additional 8 hours.
Afterwards, cells were harvested by centrifugation, washed
twice with M9* medium, plated in appropriate dilutions to
M9* plates containing 10 mM succinate as carbon source,
and incubated at 30°C for 48 h. Mutants were replica
plated on M9* medium containing 10 mM isobutyric acid
and on LB medium. Mutants unable to grow in the pres-
ence of isobutyric acid as sole carbon source were selected
for further investigations.
Enzyme assays
For the preparation of cell extracts, cells were cultivated in
M9*(pH 7.4, 20 g L-1 glucose) and depending on the plas-
mid used induced either with 1 mM IPTG or 0.05% DCPK
during exponential phase (OD450 0.5). After 4 h of induc-
tion, cells were harvested by centrifugation, washed, and
resuspended to cell density of OD450 100 in ice cold buffer
(50 mM Kpi pH 7.0, 0.5 mM dithiothreitol). Cells were
disrupted by three passages through a precooled French
press (5.5 MPa, SLM-Aminco, Rochester, NY, USA) and
cellular debris was removed by centrifugation (20 min,
17,000 g, 4°C). Cell extracts were always prepared freshly
Table 4 Bacterial strains and plasmids used in this study
Strains Relevant characteristic(s) Reference
E. coli DH5α supE44, DlacU169 (f80 lacZDM15), hsdR17 (rk-mk+), recA1, endA1, thi1, gyrA, relA [63]
E. coli DH5α ʎ-pir ʎ-pir lysogen of DH5a [64]
Ps. sp. strain VLB120 Wildtype strain [65]
Ps. sp. strain VLB120 T7 PlacUV5 T7 RNA pol, lacI
q This study
Ps. sp. strain VLB120Δbkd VLB120 with deletion of bkd, encoding subunit A of the branched-chain
α-keto acid dehydrogenase
This study
Ps. sp. strain VLB120Δbkd A10, A21, B57, B83, C18,
D67, D76, E82
NTG-mutants of Pseudomonas sp. strain VLB120 Δbkd This study
Ps. sp. strain VLB120Δbkd C18 T7 PlacUV5 T7 RNA pol, lacI
q This study
Ps. sp. strain VLB120ΔbkdΔilvE C18 T7 Ps. sp. strain VLB120Δbkd C18 ΔilvE, encoding branched-chain amino acid
aminotransferase
This study
Ps. sp. strain VLB120ΔbkdΔpycAB C18 T7 Ps. sp. strain VLB120Δbkd C18 ΔpycAB, encoding pyruvate decarboxylase This study
Ps. sp. strain VLB120ΔbkdΔleuA C18 T7 Ps. sp. strain VLB120Δbkd C18 ΔleuA, encoding 2-isopropylmalate synthase This study
Ps. sp. strain VLB120ΔbkdΔpanB C18 T7 Ps. sp. strain VLB120Δbkd C18 ΔpanB, encoding 2-ketoisovalerate
hydroxymethyltransferase
This study
Ps. sp. strain VLB120ΔbkdΔilvEΔpanB C18 T7 Ps. sp. strain VLB120ΔbkdΔilvE C18 ΔpanB, encoding 2-ketoisovalerate
hydroxymethyltransferase
This study
Ps. sp. strain VLB120ΔbkdΔilvEΔleuA C18 T7 Ps. sp. strain VLB120ΔbkdΔilvE C18 ΔleuA, encoding 2-isopropylmalate synthase This study
Ps. sp. strain VLB120ΔbkdΔilvEΔleuAΔpanB C18 T7 Ps. sp. strain VLB120ΔbkdΔilvEΔleuA C18 T7ΔpanB, encoding
2-ketoisovalerate hydroxymethyltransferase
This study
Plasmids Relevant characteristic(s) Reference
pMA-RQ-kivd Ampr, Geneart delivery vector containing kivd This study/Geneart
pCOM10 Kmr , broad host range expression vector, alk promoter, oriT, alkS
regulator gene,
[66]
pCOM10-kivd pCOM10 containing kivd This study
pCOM10-eGFP pCOM10 containing eGFP This study
pBR22b Cmr, mob lacIq Kmr PT7Ф10 [67]
pBR22b-kivd pBR22b containing kivd This study
pBR22b-alsS pBR22b containing alsS This study
pBR22b-ilvC pBR22b containing ilvC This study
pBR22b-ilvD pBR22b containing ilvD This study
pBR22b-alsS-km Cmr, Kmr, pBR22b-alsS with BoxI blunt end inserted Kmr This study
pPAPC-km pBR22b-alsS-km additionally containing ilvC This study
pBR22b-eGFP pCOM10 containing eGFP This study
pBR22b-eGFP-km Cmr, Kmr pBR22b-eGFP with BoxI blunt end inserted Kmr This study
pCOM8 Gmr, broad-host-range expression vector, alk promoter, oriT, alkS
regulator gene
[66]
pCOM8-T7-ilvD pCOM8 containing ilvD This study
pPDPK pCOM8-T7-ilvD containing kivd This study
pJQ200SK Gmr, suicide vector, P15A ori sacB RP4 pBluescriptSK MCS [68]
PJQ200SK-bkd-KO Knock-out vector This study




pJTN-cre Gmr, encodes cre recombinase Nick Wierckx
(unpublished data)
pUC18 mini-Tn7-Gm-T7 pUC18, mini-Tn7-Gm, PlacUV5 T7 RNA pol, lacI
q [52]
pUC18 mini-Tn7-Gm-T7 pUC18, mini-Tn7-Gm, PlacUV5 T7 RNA pol, lacI
q [52]
pTNS1 Ampr, TnsABCD [69]
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Table 4 Bacterial strains and plasmids used in this study (Continued)
pEMG Kmr, oriR6K, lacZa with two flanking I-SceI sites [64]
pSW-2 Gmr, oriRK2, xylS, Pm→ I-SceI [64]
pEMG-pycAB-KO Knock-out vector This study
pEMG-ilvE-KO Knock-out vector This study
pEMG-leuA-KO Knock-out vector This study
pEMG-panB-KO Knock-out vector This study
Ampr: ampicillin resistance; Cmr: chloramphenicol resistance; Kmr: kanamycin resistance; Gmr: gentamicin resistance.
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mined using the Bradford protein assay [71].
The activity of acetolactate synthase (AlsS) was assayed
according to Lang et al. [73], using 50 mM Kpi buffer
(pH 7.0). The activity of ketol-acid reductoisomerase (IlvC)
was determined according to Leyval et al. [74]. The assay
was coupled to the activity of AlsS using 50 mM pyruvate
as substrate instead of 2-acetolactate. The activity of dihy-
droxy acid dehydratase (IlvD) was quantified according to
Atsumi et al. [75]. The substrate, 2,3-dihydroxy-isovalerate
was purchased from SelectLab Chemicals GmbH (Bönen,
Germany). The assay was conducted at 30°C for 30 min.
2-keto acid decarboxylase (Kivd) activity was determined
by measuring the isobutyraldehyde concentration using
HPLC analysis. Therefore, 500 μL 50 mM potassium phos-
phate buffer (pH 7.0) containing 10 mM MgCl2, 0.5 mM
thiamine diphosphate, cell free extract, and 10 mM 2-KIV
was incubated at 30°C for 30 min. The reaction was started
by the addition of 2-KIV and stopped by the addition of
10 μL pure perchloric acid.Analytical methods
Cell densities were monitored by measuring the optical
density at 450 nm (OD450) using a spectrophotometer
(Biochrom Libra S12, Cambridge, UK). One OD450 unit
corresponds to 0.186 gcdw L
-1 for Ps. sp. strain VLB120.
Organic acids, sugars, alcohols and aldehydes were de-
tected by HPLC (LaChrom Elite, Merck Hitachi, Darmstadt,
Germany) equipped with a Trentec 308R-Gel.H ion ex-
clusion column (300 × 8 mm, Trentec Analysentechnik,
Gerlingen, Germany). The following conditions were ap-
plied; temperature: 40°C, isocratic flow rate: 1.0 ml min-1,
solvent: 5 mM H2SO4, injection volume: 20 μL. Analytes
were detected either by a UV (λ = 210 nm) or RI detector.
Lower product concentrations (< 500 μM analyte) were
quantified on a Finningan Focus GC (Thermo Electron
Corporation, Dreireich, Germany) with a Rt-βDex-sm
column (30 m × 0.25 mm × 0.25 μm, Restek GmbH,
Bad Homburg, Germany): GC oven temperature was
40°C for 5 min before it was increased to 80°C at a rate
of 20°C min-1, and to 105°C at a rate of 7°C min-1. The
maximum temperature of 200°C was reached at a rate of
60°C min-1 and kept for 3 min. Samples were extractedwith 1:1 (v/v) ice cold diethyl ether containing 0.2 mM
dodecane as internal standard.
eGFP fluorescence was measured using a microtiter plate
reader (Infinite M200, Tecan, Mannedorf, Switzerland) at
488 nm and 511 nm for excitation and emission, respect-
ively. Cells were harvested by centrifugation, washed and
resuspended in 50 mM Tris buffer pH 8.0. Biomass con-
centrations were adjusted to OD450 0.4 using 50 mM Tris-
Cl pH 8.0.
DNA manipulation
Restriction enzymes, T4 ligase, thermosensitive alkaline
phosphatase, T4 polynucleotide kinase, and high-fidelity
phusion DNA polymerase were purchased from Fermentas
GmbH (St. Leo-Rot, Germany). All enzymes were used ac-
cording to supplier’s recommendations. Plasmid DNA was
isolated with a miniprep Kit (Peqlab GmbH, Erlangen,
Germany). Gel extraction and DNA purification were per-
formed with a NucleoSpin Gel and PCR clean-up Kit
(Macherey-Nagel GmbH, Düren, Germany). All DNA ma-
nipulations were performed using standard procedures
[71]. Restriction sites, which were added to the respective
DNA fragments using PCR amplification, are listed in the
primer section (Additional file 1: Table S2).
Transformations were performed by electroporation
(2500 V, Equibio EasyjecT Prima, Ashford, UK) using
sucrose-treated competent cells [76] and glycerol-treated
competent cells [71] for Ps. sp. strain VLB120 and E. coli
DH5α, respectively.
pCOM-based plasmid construction
The kivd gene was artificially synthesized (Geneart AG,
Regensburg, Germany) in pMA-RQ-kivd based on avail-
able sequence data of Lactococcus lactis subsp. lactis strain
IFPL730 (GenBank: AJ746364). kivd was cut from the
original delivered plasmid at artificially inserted restric-
tion sites NdeI and AscI and ligated into pCOM10 cre-
ating pCOM10-kivd. eGFP was amplified using primers
KL35/36 digested and ligated into pCOM10 to create
pCOM10-eGFP.
Single gene pBR22b constructs
pCOM10-kivd was cut with NdeI and SalI and the frag-
ment was ligated into pBR22b creating pBR22b-kivd.
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omic Bacillus subtilis DNA using primers KL1/2 and KL3/
4, respectively, which were designed based on available se-
quence data (Genbank: AP012496 region: 3537181). The
fragment was ligated into pBR22b creating pBR22b-alsS.
To ensure an appropriate antibiotic selection pressure in
Ps. sp. strain VLB120, a kanamycin cassette was amplified
from pJQhdp::Km by primers KL11/12 and the phos-
phorylated fragment was ligated into dephosphorylated
pBR22b-alsS cut with BoxI, creating pBR22b-alsS-Km.
ilvC (PVLB_03705) and ilvD (PVLB_01425) were ampli-
fied from genomic Ps. sp. strain VLB120 DNA using
primers KL 5/6 and KL 7/8, respectively. The fragments
were inserted in pBR22b creating pBR22b-ilvC and
pBR22b-ilvD.
eGFP was amplified using primer KL35/36 digested and
ligated into pBR22b to create pBR22b-eGFP.
Construction of pPAPC-Km and pPDPK
ilvC including the T7 promoter and the ribosomal binding
site (RBS) was amplified from pBR22b-ilvC with primers
KL13/14. The fragments were inserted into the dephos-
phorylated vector pBR22b-alsS-Km creating pPAPC-Km.
ilvD including the T7 promoter, the RBS, and the T7 ter-
minator was amplified from pBR22b-ilvD using primers
KL29/30 and the phosphorylated, digested fragment was
ligated into the dephosphorylated Bst1107I cut pCOM8
creating pCOM8-ilvD. Orientation of the fragment was
determined using XhoI restriction and the vector with the
same orientation of ilvD and Gmr cassette was used for
further work.
kivd including the T7 promoter, and the RBS was ampli-
fied from pBR22b-kivd using primers KL27/28 and the
phosphorylated, cut fragment was ligated into the dephos-
phorylated, restricted pCOM8-ilvD creating pPDPK.
Gene deletion (Δbkd)
Deletion of the gene coding for subunit A of the branched
chain α-keto acid dehydrogenase (bkd) was achieved as
described earlier using pJQ200SK [68]. For the construc-
tion of pJQ200bkd::Km, genomic Ps. sp. strain VLB120
DNA was used as template to amplify the up- and down-
stream fragment of bkd using primers K15/16 and K17/
18. Kmr-loxP was cut from pJQhdp::Km with XbaI and
purified by gel electrophoresis. All three parts were ligated
in one pot and Ps. sp. strain VLB120 was transformed
with the verified vector. Kanamycin resistance was used
to prove genomic integration of pJQ200bkd::Km. To dis-
tinguish between single crossover and double crossover
events, mutants were screened by replica plating for
kanamycin resistance and gentamycin sensitivity. Positive
clones were confirmed using colony PCR with primers
KL15/18. Kmr-cassette was removed by using cre recom-
binase. Positive mutants were transformed with pTnCreand a single colony was picked to inoculate a 5 mL LB
culture including 0.1 mM sodium salicylate to induce cre
recombinase expression. After 4 h, the culture was appro-
priately diluted and resulting kanamycin sensitive colonies
were cured from pTNCre by subsequent inoculation and
screening for gentamycin sensitive colonies.
Gene deletions (ΔilvE, ΔleuA, ΔpanB, ΔpycAB)
To obtain all other deletion mutants, the recently pub-
lished gene editing method for Pseudomonas species
using the pEMG/pSW-2 system was used [64]. This sys-
tem allows faster identification of positive clones com-
pared to the pJQ200SK method. Up- and downstream
regions of the desired genes were amplified by PCR
using the following primers (KL19/20 and KL21/22 for
ilvE, KL23/24 and KL25/26 for pycAB, KL37/38 and
KL39/40 for leuA, KL41/42 and KL43/44 for panB) and
purified via gel electrophoresis. The resulting up- and
downstream fragments were fused by PCR using primers
(KL19/22 for ilvE, KL23/26 for pycAB, KL37/40 for
leuA, KL41/44 for panB) and after gel electrophoresis,
cut and ligated into the identically treated pEMG vec-
tors. Ps. sp. strain VLB120 was transformed with the re-
spective plasmids and single crossover mutants were
identified using cPCR. Positive clones were transformed
with pSW-2. I-SceI nuclease activity was already present
in Ps. sp. strain VLB120 pSW-2 without additional in-
duction of xylS with 3-methylbenzoate, thus colonies
were replica plated to screen for kanamycin sensitive
mutants. Gene deletion mutants were identified by cPCR
using primers KL31/32 for ilvE, KL33/34 for pycAB,
KL45/46 for leuA, and KL47/48 for panB. Positive clones
were cured from the pSW-2 plasmid by repeated inocula-
tion and screening for gentamycin sensitive mutants.
Construction of Pseudomonas sp. strain VLB120 T7
To establish Ps. sp. strain VLB120 as host for aerobic fer-
mentations, the gene encoding for a T7 RNA polymerase
under the control of a UV5 promoter and its regulator
gene lacIq were integrated in the genome using a Tn7-
transposon. Kmr-loxP, was isolated from pJQhdp::Km with
XbaI, purified by gel electrophoresis and ligated into XbaI
cut, dephosporylated mini-Tn7-T7-Gm creating mini-Tn7-
T7-KmLoxP. Ps. sp. strain VLB120 was transformed by
electroporation with mini-Tn7-T7-KmLoxP and pTNS1
and kanamycin resistant mutants were checked by cPCR
and primers KL9/10 for correct genomic integration of
genes coding for lacIq and T7 RNA polymerase. The Kmr-
cassette was removed as described above. To compare the
effectiveness of the two different expression systems, eGFP
fluorescence was used as a fast and easily detectable read-
out for expression (Additional file 1: Figure S2). Depending
on the carbon source, the fluorescence signal is about 3–6
fold higher in pBR22b-eGFP carrying strains, as compared
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highest eGFP levels could be obtained on citrate as carbon
source whereas in the presence of glucose only half of the
fluorescence signal could be measured. The biggest differ-
ence was observed in complex medium; an approximately
6-fold higher eGFP concentration could be detected in Ps.
sp. strain VLB120 pBR22b-eGFP. With regard to the fer-
mentative production of isobutyric acid, the utilization of
complex medium compounds might increase the max-
imum achievable product concentrations (Table 1 [61]). In
addition, the eGFP expression for pBR22b as well as for
pCOM10 was found to be tightly controlled in Ps. sp.
strain VLB120 (T7). Without induction only a negligible
amount of eGFP expression was detected.
Additional file
Additional file 1: Oligonucleotides used in this study (Table S1),
lists of putative aldehydeand alcohol dehydrogenases of
Pseudomonas sp. strain VL120 (Table S2+3) and supplemental
experimental data (Figure S1-5).
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